Registry for Prostate Cancer Focal Therapy | MicrobiomeTrials← Back to trialsNCT07792590
Registry for Prostate Cancer Focal Therapy
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-10-31Est. Completion: 2030-11-30
Enrollment target: 200 participants Locations- Queen Mary Hospital, Hong Kong, Hong Kong, Hong Kong
Other microbiome trials you might be interested in
PROSTATE CANCERMetastatic Prostate CancerMetastatic Prostate Carcinoma
The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utili…
Boston, United StatesEst. completion Aug 28, 2027
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate CancerProstate Carcinoma
This is a single-center, open-label, study of Prostate-Specific Membrane Antigen (PSMA)-targeted radionuclide therapy wi…
San Francisco, United StatesEst. completion May 31, 2027